CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chongqing Sansheng Industrial Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chongqing Sansheng Industrial Co Ltd
No.199 Shengxing Street
Sansheng Town, Beibei District
Phone: +86 2368239069p:+86 2368239069 CHONGQING, CHO  400714  China Ticker: 002742002742
Business Summary
Chongqing Sansheng Industrial Co Ltd is a China-based company principally engaged in the business of building materials chemicals and pharmaceutical manufacturing. The main products of the building materials chemicals segment are commercial concrete, water reducers, expansion agents, sulfuric acid, cement components and others. The main products of the pharmaceutical manufacturing segment are pharmaceutical intermediates, active pharmaceutical ingredients and preparations. The pharmaceutical intermediates include procaine hydrochloride, cefoxitin acid intermediates, chloramphenicol intermediates and others. The active pharmaceutical ingredients include acetaminophen, cloperidine hydrochloride, levofloxacin mesylate and others. The preparation products include compound acetaminophen diphenhydramine tablets, cloperidine hydrochloride tablets, clarithromycin sustained-release tablets and others. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3273 Ready-mixed concrete
2899 Chemicals and chemical preparations, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HuanYan 9/29/2022 9/29/2022
Chief Financial Officer ZhongqiangHuang 48 4/21/2023 4/21/2023
General Manager, Director ZhiqiangZhang 56 4/10/2023 9/29/2022
7 additional Officers and Directors records available in full report.

Business Names
Business Name
002742
Chongqing Chunrui Pharmaceutical and Chemical Co. Ltd.

General Information
Number of Employees: 2,039 (As of 12/31/2023)
Outstanding Shares: 432,000,000 (As of 9/30/2024)
Shareholders: 13,146
Stock Exchange: SHE
Fax Number: +86 2368340020


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025